Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Dupilumab

Arthralgia, asthma exacerbation and eosinophilic pneumonia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat De Corso E, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL). Allergy 78 : 2669-2683, Oct 2023. Available from: URL: https://dx.doi.org/10.1111/all.15772 De Corso E, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL). Allergy 78 : 2669-2683, Oct 2023. Available from: URL: https://​dx.​doi.​org/​10.​1111/​all.​15772
Metadaten
Titel
Dupilumab
Arthralgia, asthma exacerbation and eosinophilic pneumonia
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52601-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Thiamylal-sodium

Case report

Nivolumab